Amorcyte, Inc Opens Cell Therapy Trial For Cardiovascular Disease At Emory University
Amorcyte Inc (Amorcyte), a privately funded cell therapy company developing products to treat cardiovascular disease, announced today that its Phase I clinical trial is now open at Emory University School of Medicine, under Arshed A. Quyyumi, M.D., FRCP, FACC, Professor of Medicine, Cardiology, and is expected to open in another center within 90 days. "In many ways this is an important and unique Phase I trial for the developing field of cell therapies for cardiovascular disease", states Dr. Quyyumi. "In addition to safety, this trial will assess the effect of stem cell dose on definitive clinical endpoints following administration after myocardial infarction."
Read more
Click Following
http://www.medicalnewstoday.com/medicalnews.php?newsid=44609
Read more
Click Following
http://www.medicalnewstoday.com/medicalnews.php?newsid=44609
posted by Hosting Expert @ 9:33 AM
1 Comments:
At 2:25 PM,
Anonymous said…
Hi
Thanks for the great blog. I really enjoyed reading it. In fact if I were you I would go to http://www.autosurfmonster.com/ and submit this blog so thousands of others can see it for free. I am not trying to advertise for anyone, I just feel like more people should have the opportunity to see this blog and I also got a lot of free hits from them for my own blogs.. Well anyways, I look forward to all the updates.
Jessica
Post a Comment
<< Home